Key result
Chronic hemodialysis did not enhance the risk of malignant arrhythmias in patients with end-stage kidney disease, with no malignant ventricular arrhythmias detected during 96-hour monitoring.
Why the study?
Does chronic hemodialysis increase the risk of malignant arrhythmias in patients with end-stage kidney disease?
Observational (n=15)
Does chronic hemodialysis increase the risk of malignant arrhythmias in patients with end-stage kidney disease?
Answers are grounded in this paper and cite their sources.
Chronic hemodialysis itself does not appear to increase the risk of malignant arrhythmias in patients with end-stage kidney disease, suggesting that previously reported high risks may be due to other factors like underlying disease or electrolyte shifts.
UNLABELLED: Patients with end-stage kidney disease undergoing chronic maintenance dialysis (HD) are a high risk group for sudden death due to cardiovascular complications. It was the aim of the study to investigate the quantity and quality of arrhythmias during HD and between two consecutive HD (interval, I) with regard to the reproducibility of the expected results. 15 patients (8 males, 7 females) underwent continuous Holter monitoring (LT-ECG) under ambulatory conditions over 96 h including two HD ( HD1 + HD2 ) and two intervals (I1 + I2). The LT-ECG recordings were analysed with the computer assisted ' Multipass -Scanning' system with regard to heart rate (HR), supraventricular premature beats (SPB), ventricular ectopics (PVC) and malignant ventricular arrhythmias. RESULTS: The HR demonstrated a typical, well-known circadian pattern with remarkable increase of the HR during each HD. Except for rare, single SPB and/or PVC, no supraventricular or ventricular arrhythmias could be detected reproducibly. Single PVC occurred in patients with a lower potassium value. No malignant ventricular arrhythmias were found. In comparison to previously published studies, which demonstrated a high incidence of malignant ventricular arrhythmias, these conflicting results were due to differences in patients' recruitment (underlying disease, age, etc.), the performance of HD (duration, ion concentration of the dialysate etc.), serum potassium levels and drug medication (digitalis, quinidine). In summary, chronic HD per se did not enhance the risk of malignant arrhythmias in patients with end-stage kidney disease.
No takes yet. Share an insight, caveat, or question.
Wéber et al. (2008) conducted an observational in End-stage kidney disease undergoing chronic maintenance dialysis (n=15). Chronic hemodialysis vs. Interval between hemodialysis sessions was evaluated on Quantity and quality of arrhythmias (heart rate, supraventricular premature beats, ventricular ectopics, and malignant ventricular arrhythmias). Chronic hemodialysis did not enhance the risk of malignant arrhythmias in patients with end-stage kidney disease, with no malignant ventricular arrhythmias detected during 96-hour monitoring.
Synapse has enriched 10 related papers. Consider them for comparative context: